Boehringer, Sanofi Must Divest To Clear $24B Deal In Mexico
German pharmaceutical company Boehringer Ingelheim GmbH and French drugmaker Sanofi SA must sell five animal vaccines to obtain approval of a €23 billion ($24 billion) asset swap in Mexico, the country's...To view the full article, register now.
Already a subscriber? Click here to view full article